|
|
 |
Recommended Results |
| |
|
|
| 公司介绍 |
| |
Venturepharm Laboratories Limited, a member of Venturepharm Holdings, a listed company on the Hong Kong Stock Market (8225).
VPSAPI’s expertise in organic synthesis, process development and a c, and controlled supply chain, and coupled with a record of over 20 patents application annually , ensures the satisfaction from the most demanding customers of bulk APIs with high quality and competitive price.
Key services include:
· Develop specific-structure compounds preparation techniques
· Customer synthesis of milligram to kilogram quantities
· Large scale synthesis and commercial manufacturing
· Process research, development and optimization
· Analytical services |
| 相关产品 |
| |
Adapalene, Mizolastine, levosimendan , Letrozole , Azelidipine, Dopexamine hydrochloride, Zoledronic Acid, Febuxostat, Naratriptan , Riluzole, Voriconazole, Blonanserin , Otilonium Bromide, Cidofivor , Agomelatine, Pramipexole dihydrochloride, Liranaftate, Anagrelide, CAS:132741-81-2, Escitalopram Oxalate |
| 公司基本资料 |
|
| 公司名称: |
Venturepharm Laboratories Limited |
| 连络: |
联络我们
|
| 网址: |
********
********
|
| 电话: |
86-10-88500088 |
| 传真: |
86-10-88500080
|
| 国家: |
中国 |
| 住址: |
Venturepharm Towers, NO.3 Jinzhuang, Si Ji Qing, Haidian District, Beijing, 100097, China |
|
| 产品橱窗 |
|
|
|
|
|
